Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-199

First 199 Last

Share
Profile

Follow
LearningEachDay

7,029 Posts.

2335

06/12/20

00:38

Post #: 49371341
Share

Originally posted by DocMcstuffins: ↑

This is why trials are necessary, as I keep harping on about.

The vitamin C case is interesting, but use of vitamin C infusions for sepsis has been debated for ages, with some large RCTs showing benefit, and some not. These are randomised studies with proper controls and reasonable numbers of patients (>200). Despite the studies, there's still massive debate and, where I work, we do not use vitamin C infusions in sepsis. I've never seen it used elsewhere tbh.

So the jury is out. And those of you worrying that vitamin C infusions will be a competitor to MSB is wildly amusing tbh. It was an N of 1. Similar to an N of 12 it is virtually meaningless. It means there may be something there, but that guy very likely would have recovered without the vitamin C. Or maybe recovered faster without it. Or maybe it saved his life.

This is all very complex and no one really understands it. There's theories on the mechanism but whether any of that translates into clinical results is guess work.

Hence studies. But even then, with a simple therapy and large studies there are competing groups arguing about efficacy. This is where meta analyses are useful. Studies of studies.

I'm rambling a bit but the crux of this message is don't worry about the vitamin c thing. Hold tight for results to see if MSCs are feasible. And don't be caught off guard when the results come out, whether good or bad.

GLTAH

Expand

Flip a coin 12 times. On 10 of those flips, it comes up heads. Is the coin weighted? It's only an N of 12.

https://www.omnicalculator.com/statistics/coin-flip-probability

Experiment specifics
Number of flips

I want to have
at least

heads

Probability of success
Probability
0.019287

Chance of success
1.93
%

MSB Price at posting: $4.32 Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

USL

'Defining moment' for Unico as miner expands Joaquin's mineralised footprint

Monday's HotCopper trends: Imugene responses, Trigg upgrade | July 14

AII

Inside the depths of Panasqueira: A legacy carved in rock

ASN

Last hurdle for Anson's Green River plant as Korean partner looks over brine

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

First 199 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.66		Change 0.005(0.30%)		Mkt cap ! $2.121B

Open	High	Low	Value	Volume
$1.65	$1.67	$1.63	$2.841M	1.715M

Buyers (Bids)

No.	Vol.	Price($)
25	75491	$1.66

Sellers (Offers)

Price($)	Vol.	No.
$1.67	41049	19

View Market Depth

No.	Vol.	Price($)
41	114298	1.660
19	46729	1.655
16	200555	1.650
13	105372	1.645
13	86430	1.640

Price($)	Vol.	No.
1.665	37625	30
1.670	105933	18
1.675	66878	9
1.680	154103	12
1.685	25258	8

Last trade - 15.54pm 14/07/2025 (20 minute delay)

MSB (ASX) Chart

Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-199

'Defining moment' for Unico as miner expands Joaquin's mineralised footprint

Monday's HotCopper trends: Imugene responses, Trigg upgrade | July 14

Inside the depths of Panasqueira: A legacy carved in rock

Last hurdle for Anson's Green River plant as Korean partner looks over brine

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-199

Top Stories

'Defining moment' for Unico as miner expands Joaquin's mineralised footprint

Monday's HotCopper trends: Imugene responses, Trigg upgrade | July 14

Inside the depths of Panasqueira: A legacy carved in rock

Last hurdle for Anson's Green River plant as Korean partner looks over brine

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News